“`html
Humana (HUM) reported quarterly earnings of $6.27 per share for the quarter ended June 2025, missing the Zacks Consensus Estimate of $6.32 per share and down from $6.96 per share in the same quarter a year prior. The company’s revenues for the same period were $32.39 billion, exceeding the Zacks Consensus Estimate by 1.93% and up from $29.38 billion year-over-year.
This earnings miss represents a surprise of -0.79%, following an unexpected earnings beat of +16.03% in the previous quarter. Humana has surpassed consensus EPS estimates three times over the last four quarters and has seen its shares decline by 8.3% since the start of the year, in contrast to the S&P 500’s gain of 8.3%.
Looking ahead, the current consensus EPS estimate for the next quarter stands at $2.55 on revenues of $31.14 billion, while for the fiscal year, the estimate is $16.37 on $126.1 billion in revenues. The Zacks Industry Rank for Medical – HMOs is in the bottom 5% of over 250 industries, indicating potential headwinds for Humana’s stock performance.
“`
